These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

737 related items for PubMed ID: 12526712

  • 1. Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer.
    Kursa M, Walker GF, Roessler V, Ogris M, Roedl W, Kircheis R, Wagner E.
    Bioconjug Chem; 2003; 14(1):222-31. PubMed ID: 12526712
    [Abstract] [Full Text] [Related]

  • 2. Low molecular weight linear polyethylenimine-b-poly(ethylene glycol)-b-polyethylenimine triblock copolymers: synthesis, characterization, and in vitro gene transfer properties.
    Zhong Z, Feijen J, Lok MC, Hennink WE, Christensen LV, Yockman JW, Kim YH, Kim SW.
    Biomacromolecules; 2005; 6(6):3440-8. PubMed ID: 16283777
    [Abstract] [Full Text] [Related]

  • 3. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo.
    Wightman L, Kircheis R, Rössler V, Carotta S, Ruzicka R, Kursa M, Wagner E.
    J Gene Med; 2001; 3(4):362-72. PubMed ID: 11529666
    [Abstract] [Full Text] [Related]

  • 4. Pegylated polyethylenimine-Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells.
    Merdan T, Callahan J, Petersen H, Kunath K, Bakowsky U, Kopecková P, Kissel T, Kopecek J.
    Bioconjug Chem; 2003; 14(5):989-96. PubMed ID: 13129403
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery.
    Ogris M, Brunner S, Schüller S, Kircheis R, Wagner E.
    Gene Ther; 1999 Apr; 6(4):595-605. PubMed ID: 10476219
    [Abstract] [Full Text] [Related]

  • 7. Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers.
    Park MR, Han KO, Han IK, Cho MH, Nah JW, Choi YJ, Cho CS.
    J Control Release; 2005 Jul 20; 105(3):367-80. PubMed ID: 15936108
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Galactosylated poly(ethylene glycol)-chitosan-graft-polyethylenimine as a gene carrier for hepatocyte-targeting.
    Jiang HL, Kwon JT, Kim EM, Kim YK, Arote R, Jere D, Jeong HJ, Jang MK, Nah JW, Xu CX, Park IK, Cho MH, Cho CS.
    J Control Release; 2008 Oct 21; 131(2):150-7. PubMed ID: 18706946
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
    Jiang YY, Liu C, Hong MH, Zhu SJ, Pei YY.
    Bioconjug Chem; 2007 Oct 21; 18(1):41-9. PubMed ID: 17226956
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Targeted gene delivery mediated by folate-polyethylenimine-block-poly(ethylene glycol) with receptor selectivity.
    Cheng H, Zhu JL, Zeng X, Jing Y, Zhang XZ, Zhuo RX.
    Bioconjug Chem; 2009 Mar 18; 20(3):481-7. PubMed ID: 19191579
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tumor-targeted gene delivery: an attractive strategy to use highly active effector molecules in cancer treatment.
    Kircheis R, Wightman L, Kursa M, Ostermann E, Wagner E.
    Gene Ther; 2002 Jun 18; 9(11):731-5. PubMed ID: 12032698
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.